On Friday, Merck & Co. announced its oral antiviral drug molnupiravir reduced the rate of hospitalization or death by roughly 50% in participants with mild or moderate Covid-19. But while most headlines treated the drug as just one new "tool in the toolbox" for treating Covid-19, Advisory Board's Pam Divack argues it's a "much bigger" deal than that—and could drive a paradigm shift for the pandemic.
After one of his employees tested positive for Covid-19, Travis Warner and his wife both got Covid-19 tests at a freestanding ED. Then, Warner got a bill for $56,384, Aneri Pattani reports for Kaiser Health News.
Chemotherapy has long been considered the "dogma" for cancer treatment—but now, a growing number of patients are being spared the grueling treatment. Here's what the revolution in cancer care means for patients, providers, and payers, according to Advisory Board's Deirdre Saulet.
David Julius, a professor of physiology at the University of California, San Francisco, and Ardem Patapoutian, a molecular biologist and neuroscientist at the Scripps Research Institute, have won this year's Nobel Prize in physiology or medicine. Here's how their work illuminated how humans sense temperature and touch—and how it could spur new medical treatments in the future.
California Gov. Gavin Newsom announced that the state will mandate Covid-19 vaccines for all eligible public and private school students, in today's bite-sized hospital and health industry news from California, District of Columbia, and Texas.